J. E. Altwein

567 total citations
49 papers, 353 citations indexed

About

J. E. Altwein is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, J. E. Altwein has authored 49 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in J. E. Altwein's work include Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Hormonal and reproductive studies (8 papers). J. E. Altwein is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Hormonal and reproductive studies (8 papers). J. E. Altwein collaborates with scholars based in Germany, United Kingdom and Italy. J. E. Altwein's co-authors include Ewald Wöll, Martin Burkart, I.M. Holdaway, Eberhard Varenhorst, Francesco Boccardo, G. Lunglmayr, Jacques‐Antoine Haefliger, C. Tyrrell, W. Thon and Peter Boyle and has published in prestigious journals such as Cancer, The Journal of Urology and European Urology.

In The Last Decade

J. E. Altwein

43 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. E. Altwein Germany 9 202 115 79 73 57 49 353
C Schulman Belgium 7 248 1.2× 64 0.6× 37 0.5× 52 0.7× 24 0.4× 13 312
Sergio Concetti Italy 12 168 0.8× 47 0.4× 68 0.9× 137 1.9× 22 0.4× 25 395
Luis Resel Spain 8 131 0.6× 126 1.1× 262 3.3× 197 2.7× 73 1.3× 30 524
M. STOTT United Kingdom 12 267 1.3× 66 0.6× 199 2.5× 164 2.2× 27 0.5× 24 581
Ho Seok Chung South Korea 10 133 0.7× 54 0.5× 45 0.6× 91 1.2× 26 0.5× 48 320
Tomoteru Kishimoto Japan 11 70 0.3× 83 0.7× 39 0.5× 137 1.9× 72 1.3× 33 310
James L. Bailen United States 11 312 1.5× 161 1.4× 66 0.8× 67 0.9× 82 1.4× 41 518
Bradley Holland United States 10 159 0.8× 48 0.4× 136 1.7× 71 1.0× 35 0.6× 20 301
L. Romis Italy 9 178 0.9× 58 0.5× 55 0.7× 89 1.2× 57 1.0× 17 329
Choal Hee Park South Korea 13 147 0.7× 49 0.4× 205 2.6× 103 1.4× 15 0.3× 38 429

Countries citing papers authored by J. E. Altwein

Since Specialization
Citations

This map shows the geographic impact of J. E. Altwein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. E. Altwein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. E. Altwein more than expected).

Fields of papers citing papers by J. E. Altwein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. E. Altwein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. E. Altwein. The network helps show where J. E. Altwein may publish in the future.

Co-authorship network of co-authors of J. E. Altwein

This figure shows the co-authorship network connecting the top 25 collaborators of J. E. Altwein. A scholar is included among the top collaborators of J. E. Altwein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. E. Altwein. J. E. Altwein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Altwein, J. E.. (2010). The Combination of LH-RH Analogues with other Treatment Modalities in Prostate Cancer. Recent results in cancer research. 153. 71–81.
2.
Altwein, J. E., et al.. (2009). Möglichkeiten zur Differentialdiagnose der Infertilität mit dem LH-(ICSH-)FSH-Radioimmuntest Experimentelle Untersuchungen. Andrologia. 4(4). 343–350. 1 indexed citations
4.
Ebert, Thomas, et al.. (2002). Diätetische Prävention des Mamma- und Prostatakarzinoms: Grundlagen und Praxis des Nutritional Cancer Prevention (NCP)-Programms. DMW - Deutsche Medizinische Wochenschrift. 127(25/26). 1392–1396. 1 indexed citations
5.
Altwein, J. E., et al.. (2002). Prävention und komplementärmedizinische Maßnahmen beim Altern. Der Urologe. 41(4). 318–324. 1 indexed citations
7.
Altwein, J. E., K.-H. Bichler, Johannes Hüsing, et al.. (1999). Screening for early prostate cancer in Germany. Preliminary results of a prospective multicenter trial. Der Urologe. 38(2). 114–123. 11 indexed citations
8.
Kirby, Roger, Chris Robertson, A. Turkes, et al.. (1999). Finasteride in association with either flutamide or goserelin as combination hormonal therapy in patients with stage M1 carcinoma of the prostate gland. The Prostate. 40(2). 105–114. 29 indexed citations
9.
Altwein, J. E.. (1999). Prostatic carcinoma with positive lymph nodes – the case for primary hormone therapy. Der Urologe. 38(4). 337–343. 3 indexed citations
10.
Altwein, J. E., et al.. (1999). Prognostic Factors for Carcinoma of the Prostate. Urologia Internationalis. 63(1). 62–71. 3 indexed citations
11.
Altwein, J. E.. (1998). Kontroversen der palliativen Hormontherapie des metastasierenden Prostatakarzinoms. Der Urologe B. 38(7). S2–S9. 2 indexed citations
12.
Bartha, Robert, J. E. Altwein, & D. Hölzel. (1996). Epidemiologie, Ätiologie und natürlicher Krankheitsverlauf des Prostatakarzinoms. Der Onkologe. 2(3). 208–213.
13.
Tyrrell, C., J. E. Altwein, Eberhard Varenhorst, et al.. (1993). Multicenter randomized trial comparing zoladex with zoladex plus flutamide in the treatment of advanced prostate cancer. Survival update. Cancer. 72(S12). 3878–3879. 23 indexed citations
14.
Beyer, Andreas, et al.. (1993). Adjuvant Hormonal Therapyfollowing RadicalProstatectomy. European Urology. 24(2). 51–56. 4 indexed citations
15.
Altwein, J. E., et al.. (1990). Efficacy and Discriminative Ability of Prostate-Specific Antigen as aTumor Marker. European Urology. 17(1). 12–16. 1 indexed citations
16.
Schneider, Wolfgang, et al.. (1989). ESWL Management of Ureteral Calculi without Anesthesia:An Alternative to Invasive Procedures. European Urology. 16(6). 405–409. 3 indexed citations
17.
Altwein, J. E., et al.. (1988). Zur Interpretationsproblematik der Urethrakonfiguration im Miktionszysturogramm (MZU) beim jungen Mädchen. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 148(2). 155–160. 1 indexed citations
18.
Rübben, H. & J. E. Altwein. (1987). [Advanced prostate cancer--a therapeutic dilemma?].. PubMed. 26(1). 7–14. 1 indexed citations
19.
Thon, W., et al.. (1987). Management and Early Reconstruction of Urinary Tract Abnormalities Detected in utero. British Journal of Urology. 59(3). 214–217. 12 indexed citations
20.
Altwein, J. E., et al.. (1985). Therapeutisches Konzept bei Hypospadieäquivalenten. Aktuelle Urologie. 16(1). 27–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026